Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience
2017
Background
As prognosis of patients with metastatic hepatocellular carcinoma (HCC) is mainly determined by intrahepatic HCC progression, local treatment with TACE may result in improved OS, although it is not recommended. The purpose of this study was to analyze retrospectively the efficacy of TACE and its impact on OS in patients with metastatic hepatocellular carcinoma (HCC).
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
32
References
12
Citations
NaN
KQI